Target intelligence / Profile preview

Marburgvirus VP24 protein (VP24)

Target
VP24
Molecular classification
Matrix protein, Nucleocapsid protein, Peripheral membrane protein
01

Overview

The Marburgvirus VP24 protein is a structural viral protein that functions as a minor matrix protein in the filovirus life cycle, distinct from its Ebola virus counterpart. It associates with lipid membranes peripherally, oligomerizes into tetramers or higher-order structures, and interacts with the nucleoprotein NP to facilitate nucleocapsid assembly and transport to budding sites at the plasma membrane. VP24 is recruited into virus-like particles induced by the major matrix protein VP40 but does not alter their morphology or budding efficiency; however, silencing VP24 expression significantly impairs infectious particle release without affecting viral transcription or replication. Its crystal structure reveals a pyramid-shaped α/β domain with conserved pockets, a projecting β-shelf, and a flexible N-terminal strand, differing from ebolavirus VP24 in lacking immunosuppressive activity. In Marburg virus infection, VP24 binds human Keap1 via K-loop cysteine residues, promoting Nrf2 nuclear accumulation and cytoprotective antioxidant responses that support viral propagation. As a critical component of the viral matrix between the nucleocapsid and envelope, VP24 is essential for forming transport-compete nt nucleocapsids and enabling progeny virion production, positioning it as a potential antiviral target despite limited approved drugs.

Other names
MARV VP24mVP24
02

Biological functions

Nucleocapsid assemblyVirion buddingVirus particle formationMembrane bindingProtein oligomerizationInteraction with nucleoprotein NP
03

Disease associations

Infection

Beyond the preview

Go deeper on Marburgvirus VP24 protein (VP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marburgvirus VP24 protein (VP24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call